Barry J. Marenberg


Articles:

  • Saturday, September 1, 2007
    The costs of developing new drugs are astounding. Estimates put the costs of developing new drugs in excess of $900 million and often approaches nearly 2 billion dollars for each new drug. This development cost, combined with the short remaining patent lifespan after regulatory approval, is the reason for the high prices charged for most drugs....
  • Wednesday, June 1, 2005
    The issue of patent marking is one that rarely appears before the Court of Appeals for the Federal Circuit. Recently, however, the Federal Circuit had the opportunity to decide a case dealing with false patent marking. The case is Clontech Laboratories, Inc. v. Invitrogen Corporation,1 a case in which the Federal Circuit was presented with "virtually an...